Usefulness of bone marrow transplantation in the Hurler syndrome

Elizabeth A Braunlin1, Nanci R Stauffer, Charles H Peters

  • 1University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA. braun002@umn.edu

Insights

Hurler syndrome, a genetic disorder, causes early death due to glycosaminoglycan buildup. This study details cardiac ultrasound findings in patients over 10 years post-bone marrow transplant.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Hurler syndrome is a rare, autosomal recessive lysosomal storage disease.
  • Progressive deposition of glycosaminoglycans (GAGs) in coronary arteries and airways leads to premature death, typically within the first decade of life.
  • Bone marrow transplantation (BMT) is a potential treatment, but long-term effects on cardiovascular health require further investigation.

Purpose of the Study:

  • To describe the cardiac ultrasound findings in patients with Hurler syndrome more than 10 years after successful bone marrow transplantation.
  • To assess the long-term cardiovascular impact of Hurler syndrome and its treatment.

Main Methods:

  • Retrospective analysis of cardiac ultrasound data.
  • Inclusion of patients with Hurler syndrome who underwent successful BMT >10 years prior.
  • Detailed echocardiographic measurements and assessment of cardiac function.

Main Results:

  • Echocardiographic data from patients >10 years post-BMT were analyzed.
  • Specific cardiac ultrasound findings related to GAG deposition and its sequelae were identified.
  • The study provides insights into the long-term cardiac status following BMT for Hurler syndrome.

Conclusions:

  • Successful bone marrow transplantation may alter the long-term cardiovascular prognosis in Hurler syndrome.
  • Cardiac ultrasound remains a crucial tool for monitoring patients post-BMT.
  • Further research is needed to fully understand the chronic cardiac implications and optimize management strategies.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...